The role of PAX6 in eye development and genetic eye disorders

	Ophthalmology & Optometry
	The latest ophthalmology / optometry news from News Medical

	The role of PAX6 in eye development and genetic eye disorders As a key transcription factor, PAX6 governs eye and brain development, with genetic alterations linked to aniridia and structural brain changes.

	Vitamin A and thyroid hormones in the retina shape fetal vision Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found.

			Myopia may be driven by prolonged close-up focus in low-light environments For years, rising rates of myopia - or nearsightedness - have been widely attributed to increased screen time, especially among children and young adults.

			Switching lens designs may enhance long-term myopia control Myopia has become a major global public health concern, with rising prevalence and earlier onset among children worldwide.

			Study examines the relationship between leukocyte telomere length and age-related cataract Cataracts remain the leading cause of blindness worldwide among adults over 50, despite major advances in surgical treatment.

			WHO validates Libya’s success in eliminating trachoma nationwide The World Health Organization (WHO) today announced that Libya has eliminated trachoma as a public health problem, a landmark victory for public health in WHO's Eastern Mediterranean Region.

	Review: Pathogenesis, diagnosis, and management of harlequin ichthyosis Harlequin ichthyosis (HI) is a rare, severe genetic skin disorder caused by ABCA12 mutations, leading to defective lipid transport and loss of skin barrier function.

	Axol Bioscience acquires ophthalmology business from Newcells Biotech Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and research, today announced that it has acquired the ophthalmology business of Newcells Biotech (Newcells), a leading drug discovery partner specializing in the development of in vitro models and bespoke assay services.

	Weight loss drug tirzepatide may lower the risk of diabetic retinopathy The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators.

	Milken Institute and Ann Theodore Foundation fund mTOR inhibitor trial for sarcoidosis The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a future clinical trial in cutaneous sarcoidosis.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026